Atara Biotherapeutics, Inc.

 Atara Biotherapeutics, Inc. contact information is shown below
Owner:ATARA BIOTHERAPEUTICS, INC.
Owner Address:611 Gateway Blvd, Suite 900 South San Francisco CA 94080
Owner Web Site
Owner Phone
Owner Toll Free
Owner Fax

 

Brands Owned byAtara Biotherapeutics, Inc.

Brand:

ALLELE

Description:

Developing pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting; conducting clinical trials of pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting; conducting clinical research of the effectiveness of pharmaceutical and therapeutic preparations, namely, by conducting clinical trial on patients with EBV-Associated Post Transplant Lymphoproliferative Disease (EBV-PTLD);

Category: DEVELOPING PHARMACEUTICAL THERAPEUTIC PREPARATIONS
Brand:

ATARA

Description:

House mark for pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting, none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis;

Category: HOUSE MARK PHARMACEUTICAL
Brand:

ATARA

Description:

house mark for pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting, none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis;

Category: HOUSE MARK PHARMACEUTICAL
Brand:

ATARA BIO

Description:

The mark consists of the phrase ATARA BIO in black lettering with an abstract design of a crown in yellow and green stacked on top of the phrase.;House mark for pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, and protein-energy wasting, none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis;The color(s) yellow, green and black is/are claimed as a feature of the mark.;

Category: